Table 2 Demographic and clinical characteristics of the 147 included patients
Variable | n (%) or mean ± SD |
|---|---|
Sex, males | 112 (76.2) |
Age, years | 65.4 (10.6) |
BMI, kg/m2 | 26.4 (4.1) |
(Previous) smoker | 68 (46.3) |
Hypertension | 79 (53.7) |
Diabetes mellitus | 16 (10.9) |
Nephrostomy catheter | 14 (10.1) |
ASA class | |
ASA class 1 | 20 (13.6) |
ASA class 2 | 91 (61.9) |
ASA class 3 | 36 (24.5) |
Indication | |
Bladder cancer | 123 (81.6) |
Stage T ≥ T2 | 73 (59.3) |
Other malignancy | 13 (8.8) |
Functional | 8 (5.4) |
Other | 3 (2.0) |
Colonization with MDRO | 7 (4.8) |
Guideline-accordant prophylaxis | 116 (78.9) |
Correct choice | 134 (91.2) |
Correct dose | 124 (92.5) |
Administration < 60 min prior to incision | 142 (91.2) |
Type of diversion | |
Ileal conduit | 120 (81.6) |
Hautmann neobladder | 27 (18.4) |
Duration surgery, minutes | 216 (75) |
Blood loss, ml | 1031 (700) |